Ledger.Open graph →
SEC Form D · filed August 17, 2021

ADARx Pharmaceuticals, Inc

Offering
$75.0M
Sold
$75.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Xiong Zhang · San Diego, CADirectorSheila Gujrathi · San Diego, CADirectorRui Zhu · San Diego, CAExecErez Chimovits · San Diego, CADirectorZhen Li · San Diego, CAExec · DirectorCarl Gordon · San Diego, CADirectorYuan Sun · San Diego, CADirectorCary Marr · GEORGE TOWN GRAND CAYMAN, Cayman IslandsDirectorDaryl Brooks · Grandview, TXExec · DirectorKevin E. Marchetti · Novi, MIDirectorAlex C. Sun · Whittier, CADirectorRuwack Trust · GREENSBORO, NCExecCharles Reim · San Francisco, CADirectorSimeon George · Cambridge, MADirectorJames D. Rippeto, Jr · Houston, TXExec · DirectorGurwinder Singh · Jericho, NYExecPaul Song · Los Angeles, CADirectorJeffrey Takimoto · Los Angeles, CADirectorRoger A. Mills · Philadelphia, PADirectorEdward Chen · Los Altos, CADirectorYuan Sun · San Diego, CADirectorSimeon George · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗